How do I switch from injectable to sublingual Semaglutide with Direct Meds?
Changes to medication form, such as moving from an injectable to a sublingual formulation, must be reviewed and approved by a licensed healthcare provider. If you believe a different formulation may better support your treatment plan, you can submit a request through your patient portal so the medical team can review it.
For Patients in the United States:
- Log into your Direct Meds portal: https://portal.directmeds.com/
- Select the Dosage Change Request option.
- Your request will be reviewed by a member of the medical team, and you will typically receive a response within 48 hours.
For Patients in Canada:
- Log into your Direct Meds Canada portal: https://caportal.direct-meds.com/user
- Submit a request for a medication change or refill.
- Please note that certain adjustments may require canceling your existing subscription before changes can be processed.
Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies under medical supervision and may differ in formulation, dosing, and supporting evidence from FDA-approved products.

This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment for any specific person